Update to the study protocol: minimisation of dialysis risk in hospital patients with chronic kidney disease (MinDial): a multicentre, stepped-wedge, cluster-randomised controlled trial
D. Stelzer, H. Binder, M. Glattacker, E. Graf, M. Hahn, M. Hollenbeck, K. Kaier, B. Kowall, N. Kuklik, G. Metzner, N. Mueller, L. Seiler, S. Stolpe, C. Blume
TL;DR
The MinDial study protocol is updated to reduce dialysis risks in hospital patients with chronic kidney disease.
Contribution
The paper provides an updated protocol for a multicentre trial aiming to minimize dialysis risks in chronic kidney disease patients.
Findings
The MinDial study is a stepped-wedge, cluster-randomised controlled trial.
The updated protocol aims to improve patient outcomes by reducing dialysis risks.
The trial is registered in the German Clinical Trials Register.
Abstract
This document reports a brief update to the previously published protocol of the MinDial study. Trial registration German Clinical Trials Register DRKS00029691. Registered on 12 Sept. 2022, https://drks.de/search/en/trial/DRKS00029691.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDialysis and Renal Disease Management · Heart Failure Treatment and Management · Chronic Kidney Disease and Diabetes